Skip to content
★ Sign in to follow
RA
Total declarations
4
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (1 ops.)
€1.3M

Latest filing published 19 Nov 2014 for Tandem Diabetes Care INC, €1,611.

Insider track record

Disclosed buys
0
Disclosed sells
1
Signal history

No signal scores available.

Robert Anacone: trading record in brief

Robert Anacone is a declared insider at 2 companies; the most frequent names are Biosite Inc and Tandem Diabetes Care Inc. Over a trading history stretching from 15 June 2007 to 14 November 2014, the count stands at 4 filings.

On the market, this insider has only sold: 1 sale, €1.3M in total. Other entries cover 2 share grants and 1 option exercise.

The latest filing, published on 19 November 2014, reports a share grant of €1,611 in Tandem Diabetes Care Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Robert Anacone

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations4 total
  • ◆
    EVP & CHIEF COMMERICAL OFFICERExecutivesTandem Diabetes Care Inc
    2,010 USD0SEC
    158 shares@ US$12.72Common StockSEC:0001209191-14-070171:0
  • ◆
    EVP & CHIEF COMMERICAL OFFICERExecutivesTandem Diabetes Care Inc
    33,826 USD0SEC
    2,653 shares@ US$12.75Common StockSEC:0001209191-14-039651:0
  • ◇
    Senior Vice President WorldExecutivesBiosite Inc
    1M USD0SEC
    18,750 shares@ US$55.23Common StockSEC:0001341150-07-000002:0
  • ▼
    Senior Vice President WorldExecutivesBiosite Inc
    2M USD0SEC
    18,750 shares@ US$92.20Common StockSEC:0001341150-07-000002:1

4 of 4 declarations